Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer.
Brett BT, Smith SC, Bouvier CV, Michaeli D, Hochhauser D, Davidson BR, Kurzawinski TR, Watkinson AF, Van Someren N, Pounder RE, Caplin ME.
Brett BT, et al. Among authors: kurzawinski tr.
J Clin Oncol. 2002 Oct 15;20(20):4225-31. doi: 10.1200/JCO.2002.11.151.
J Clin Oncol. 2002.
PMID: 12377966
Clinical Trial.